Theranostic Trop-2-directed pretargeted radioimmunotherapy for metastatic prostate cancer with curative intent Grant uri icon

Overview

date/time interval

  • May 1, 2025 - April 30, 2028

sponsor award ID

  • HT9425-25-1-0152

Affiliation